发明授权
US07521175B2 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571 有权
与STI-571抗性相关的Bcr-Abl酪氨酸激酶突变

Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
摘要:
The invention described herein relates to novel genes and their encoded proteins, termed Mutants Associated with Resistance to STI-571 (e.g., T315I Bcr-Abl), and to diagnostic and therapeutic methods and compositions useful in the management of various cancers that express MARS. The invention further provides methods for identifying molecules that bind to and/or modulate the functional activity of MARS.
信息查询
0/0